BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33258314)

  • 1. Point-of-Care Pathogen Detection with CRISPR-based Programmable Nucleic Acid Binding Proteins.
    Dhar BC; Steimberg N; Mazzoleni G
    ChemMedChem; 2021 May; 16(10):1566-1575. PubMed ID: 33258314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting pathogens with Zinc-Finger, TALE and CRISPR- based programmable nucleic acid binding proteins.
    Batista AC; Pacheco LGC
    J Microbiol Methods; 2018 Sep; 152():98-104. PubMed ID: 30076867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection.
    Bhardwaj P; Kant R; Behera SP; Dwivedi GR; Singh R
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The applications of CRISPR/Cas system in molecular detection.
    Zhou L; Peng R; Zhang R; Li J
    J Cell Mol Med; 2018 Dec; 22(12):5807-5815. PubMed ID: 30338908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing Pathogens.
    Rahman MR; Majumder TR; Apu MAI; Paul AK; Afrose A; Dash BK
    J Trop Med; 2022; 2022():5390685. PubMed ID: 36199433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas-Integrated LAMP.
    Atçeken N; Yigci D; Ozdalgic B; Tasoglu S
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
    Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
    J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease.
    Liu X; Hussain M; Dai J; Li Y; Zhang L; Yang J; Ali Z; He N; Tang Y
    Biol Proced Online; 2022 Jan; 24(1):2. PubMed ID: 35067222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas Biology and Its Application to Infectious Diseases.
    Strich JR; Chertow DS
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30429256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-based diagnostics.
    Kaminski MM; Abudayyeh OO; Gootenberg JS; Zhang F; Collins JJ
    Nat Biomed Eng; 2021 Jul; 5(7):643-656. PubMed ID: 34272525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools.
    Zhu Y; Huang Z
    Natl Sci Rev; 2019 May; 6(3):438-451. PubMed ID: 34691893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.